Clovis Oncology initiates combined clinical trial of drugs to treat lung cancer

Clovis Oncology initiates combined clinical trial of drugs to treat lung cancer

BOULDER -- Clovis Oncology, Inc. (NASDAQ: CLVS) announced it has initiated a clinical trial to evaluate a novel combination therapy of Genentechs investigational cancer immunotherapy... Read More

Thursday January 28, 2016 0 comments Tags: Clovis Oncology, Patrick Mahaffy, Boulder, rociletinib